Pre-/Post-Treatment Regulatory Cell Profiling of Human Tissue in Alopecia Areata

Study type: Research Studies Posting date: 11/12/2024 Last updated: 11/12/2024 Status: Recruiting Country: United States Eligibility:

18 years or older; diagnosed with alopecia areata; about to start an oral JAK inhibitor; able to travel to UCSF for two in-person study visits
Location: University of California at San Francisco (UCSF)
1701 Divisadero Street
San Francisco, CA 94115
Description:

Researchers at UCSF are studying how people with alopecia areata respond to current therapies with the hope of developing new and better treatments.

Study participants will be asked to donate a scalp biopsy and blood sample at two separate study visits, before and after starting on an oral JAK inhibitor medication.

Study participants may be compensated up to $350 for their time and effort.

You may qualify to participate in this study if you:

  • Are 18 years of age or older and diagnosed with alopecia areata (AA)
  • Are about to start an oral JAK inhibitor (i.e. baricitinib (Olumiant), ritlecitinib (Litfulo)) for treatment of your AA
  • Are able to return to UCSF in San Francisco for a second study visit in ~4 months

For more information, contact Ashley Yates, PA by email at ashley.yates2@ucsf.edu